Rebecca Klisovic, MD
- Specialty: Hematology and Oncology
-
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Seidman Cancer Center (0 mi.)
11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-3951
Biography: Rebecca Klisovic, MD
Titles
- Chief Medical Information Officer, UH Seidman Cancer Center
Certifications & Memberships
- Medical Oncology - American Board of Internal Medicine
Education
Research Fellowship | Medical Oncology
Medical Oncology - The Ohio State University Wexner Medical Center (2003 - 2004)
Fellowship | Medical Oncology
Medical Oncology - The Ohio State University Wexner Medical Center (2001 - 2003)
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - University Of North Carolina Health Care (2000 - 2001)
Residency | Internal Medicine
Internal Medicine - University Of North Carolina Health Care (1997 - 2000)
Medical Education
The Ohio State University College Of Medicine (1993 - 1997)
Undergraduate
Case Western Reserve University (1993)
Patient Experience Reviews
Dr. Klisovic is excellent. She is worthy of my trust because she has proved her expertise in her field. She has excellent bedside manner.
*** RN, Dr *** (fellow), and Dr Klisovic took a great deal of time with me explaining my new upsetting diagnosis. Felt so very cared for.
*** All staff and physicians have treated me with total respect
This was my initial appointment with Dr. Klisovic. She was wonderful.
Good as always
Dr Klisovic worked very hard at eradicating my bone pain. It was a priority for her and for me.
Good as always
Great experience
Dr klisovic is excellent. She is the doctor I will turn to and trust with my life. She knows what she is doing and is trustworthy. I am assertive, informed and expect excellent care. She has excelled in my every expectation
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Rebecca Klisovic did not disclose any Outside Relationships with Industry.